CDXC - ChromaDex Corporation

NasdaqCM - NasdaqCM Real-time price. Currency in USD
+0.09 (+2.17%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous close4.15
Bid3.78 x 5000
Ask5.29 x 100
Day's range4.09 - 4.29
52-week range2.30 - 7.24
Avg. volume482,398
Market cap232.505M
PE ratio (TTM)N/A
EPS (TTM)-0.25
Earnings date9 May 2018 - 14 May 2018
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est9.25
Trade prices are not sourced from all markets
  • Associated Press2 months ago

    ChromaDex reports 4Q loss

    The Irvine, California-based company said it had a loss of 17 cents per share. The natural products company posted revenue of $7.5 million in the period. For the year, the company reported that its loss ...

  • Globe Newswire3 months ago

    ChromaDex to Present at the 3rd Annual NAD+ Summit

    ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today it will sponsor a gathering of scientific leaders at the 2018 NAD+ Summit on January 26-28, 2018 in San Diego, CA. In collaboration with the Center for Research on Addiction and Brain Health, the NAD+ Treatment Center, and Springfield Wellness Center, ChromaDex will share its knowledge of nicotinamide riboside (NR) and nicotinamide adenine dinucleotide (NAD+) with leading scientists, doctors, innovators and thought leaders in the NAD+ community along with all other consumers and participants who are welcome to attend the summit. ChromaDex has enabled the proliferation of NR research by developing, commercializing and supplying NIAGEN®, which has been rigorously tested for safety and has been the subject of Notifications filed with the U.S. Food and Drug Administration (FDA).

  • Associated Press5 months ago

    ChromaDex posts 3Q profit

    The Irvine, California-based company said it had profit of 4 cents per share. Losses, adjusted to account for discontinued operations, were 7 cents per share. The natural products company posted revenue ...

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes